In contrast to the past, it now takes more than a bargain price to attract a buyer for a redundant pharma manufacturing plant. A strong strategic rationale and revenue stream need to be in the mix for the buyer to achieve viability. Executives are walking away from bargain-basement pricing because of missing long-term economics and strategic rationale. Article